ZoomMed inc.
TSX VENTURE : ZMD

ZoomMed inc.

September 10, 2008 08:00 ET

ZoomMed Sign an Agreement With One of the Most Important Pharmaceutical Company in Canada

MONTREAL, QUEBEC--(Marketwire - Sept. 10, 2008) - ZoomMed Inc. (TSX VENTURE:ZMD), developer of the ZRx Prescriber intended for use by physicians, is proud to announce the signing of an agreement with one of the most important pharmaceutical company in Canada, for the distribution of medical information to physicians using the ZRx Prescriber. The name and the amount of the agreement will be kept confidential.

"We actually have 2,200 doctors in Canada who have chosen our prescriber and that number is growing continually. An agreement with a pharmaceutical company of that scope proves that our ZRx Prescriber is now positioned as one of the best communication tool to have direct access to physicians and, in order to present, among other things, their products and compliance programs efficiently", declared Mr. Yves Marmet, President and CEO of ZoomMed.

About the ZRx Prescriber

The "ZRx Prescriber" is a Web application that runs on a pocket computer or a PC. The tool is used by physicians to fill out prescriptions and make them available to pharmacists, who can view the scripts information online via unique barcodes and confirm the scripts information using the physician's signed copy. Prescription errors (illegible handwriting, incorrect dosage, drug interactions) lead to 700 fatalities and 150,000 hospitalizations every year in Canada, representing $613 million in additional healthcare costs.

The "ZRx Prescriber" also gives physicians access to a portable source of medical information generated by the pharmaceutical companies and private or public organizations that use this revolutionary new communication tool. Thanks to the "ZRx Prescriber", thousands of Canadian physicians can now have access to vital information such as clinical studies, scientific discoveries, new product launches, medical training information and major medical alerts.

For further information on ZoomMed, the distribution and/or integration of the ZRx Prescriber to your solution, contact us through the following. You can also visit our Web Site; www.zoommed.com.

The TSX Venture Exchange does not assume any responsibility for the adequacy or accuracy of this press release.

Contact Information

  • ZoomMed Inc.
    Yves Marmet
    President and Chief Executive Officer
    450-678-5457, Ext 228
    info@zoommed.com